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The conserved histone methyltransferase Dot1 establishes an H3K79 methylation pattern consisting of
mono-, di- and trimethylation states on histone H3 via a distributive mechanism. This mechanism has been
shown to be important for the regulation of the different H3K79 methylation states in yeast. Dot1 enzymes
in yeast, Trypanosoma brucei (TbDot1A and TbDot1B, which methylate H3K76) and human (hDot1L)
generate very divergent methylation patterns. To understand how these species-specific methylation
patterns are generated, the methylation output of the Dot1 enzymes was compared by expressing them in
yeast at various expression levels. Computational simulations based on these data showed that the Dot1
enzymes have highly distinct catalytic properties, but share a distributive mechanism. The mechanism of
methylation and the distinct rate constants have implications for the regulation of H3K79/K76methylation.
A mathematical model of H3K76 methylation during the trypanosome cell cycle suggests that
temporally-regulated consecutive action of TbDot1A and TbDot1B is required for the observed regulation
of H3K76 methylation states.
H istones are heavily modified by histone modifiers, which can influence the packaging, accessibility, andusage of the genome. One of these histone modifiers is the evolutionary conserved enzyme Dot1, whichestablishes a methylation pattern of mono-, di- and trimethylation on histone H3 on lysine 79 (H3K79)1.
Dot1 has been implicated in a range of key cellular processes2–5. It is involved in gene regulation6–8, DNA damage
repair and response9,10, the pachytene checkpoint in meiosis11 and cell cycle regulation12,13. In addition, it stimu-
lates cell proliferation14 and survival of MLL-rearranged leukemic lymphocytes and breast cancer cells15–17. Given
the importance of Dot1 proteins in disease, Dot1 proteins are emerging as appealing candidates for therapeutic
intervention strategies in humans and trypanosomes5. Recently, several inhibitors of human Dot1-like protein
(hDot1L) have been developed and hDot1L inhibitors are currently being tested in clinical trials as epigenetic
treatment for MLL-rearranged leukemia18,19. Therefore, there is a broad interest in understanding the catalytic
mechanism of Dot1L and mechanisms that regulate this enzyme and the methylation patterns it generates3,20–32.
Our previous studies have shown that yeast Dot1 is a histonemethyltransferase without a SET domain and with a
non-processive (distributive) kinetic mechanism: it establishes mono, di- and trimethylation (H3K79me1, -me2
and -me3) on H3K79 via repetitive rounds of binding to and dissociation from histone H322. This implies that a
releasedH3K79mono- or dimethylation state is not necessarily the finalmethylation state and that the generation
of a highermethylation state depends on the previous lower one.Most other histonemethyltransferases contain a
conserved SET domain and generate multiple methylation states on their substrates in a processive manner21,33,34.
Changes in the activity or expression of the distributive Dot1 enzyme do not affect all H3K79 methylation states
equally but lead to characteristic changes in the relative amount of each state. Indeed, partial Dot1 inhibitiondoes not
result in an overall reduction of the number of methylated H3K79 residues, but leads to a severe loss of H3K79me3
and a gain of H3K79me121,22. Thus, understanding the mode of action of Dot1 has helped to understand the
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with the absence of a known H3K79 demethylase is that H3K79me3
accumulates on ageing histones, which makes H3K79 methylation act
as a molecular timer in the cell21,35.
The Dot1 catalytic domain and the substrate lysine on histone H3
on the nucleosome core are highly conserved22,36. Interestingly, the
global methylation patterns vary substantially between different
organisms. Whereas in yeast the majority of H3 is methylated
(,90%) andmainly in the H3K79me3 state1,22, in human andmouse
cells only a small subset of H3 is methylated, predominantly in
the form of H3K79me137. In the unicellular eukaryotic parasite
Trypanosoma brucei, the causative agent of African sleeping sickness,
two Dot1 enzymes TbDot1A and TbDot1B are responsible for
methylation of H3K76, the Trypanosoma counterpart of H3K79 in
yeast and larger eukaryotes. Interestingly, in trypanosomes the
majority of H3K76 is di- or trimethylated by TbDot1A and
TbDot1B, respectively12,23,38.
In trypanosomes, TbDot1B is required for proper silencing of
telomeric VSG expression sites, a process crucial for antigenic vari-
ation of these parasites4,39,40, normal cell cycle progression, and dif-
ferentiation of the bloodstream form to the procyclic insect stage12.
Depletion of TbDot1A and loss of H3K76me2 abolished DNA rep-
lication while TbDot1A overexpression resulted in continuous
DNA replication38. In human cells, Dot1L may also have a role in
DNA replication because H3K79me2 has been found to associate
with origins of replication to help limit DNA replication once per
cell cycle41.
Here we determined the intrinsic enzymatic properties of four
Dot1 enzymes that generate highly divergent H3K79/76methylation
patterns, namely hDot1L, TbDot1A, TbDot1B and yeast Dot1
(yDot1). To unravel their mechanism of methylation and apparent
catalytic rate constants the enzymes were studied by heterologous
expression in yeast, allowing direct comparison under identical
physiological conditions. By obtaining quantitative measurements
of H3K79 methylation patterns and combining it with computa-
tional simulations, we found that the different Dot1 enzymes share
a distributive mechanism, but show highly divergent catalytic prop-
erties reflected by distinctive rate constants.
Methods
Yeast strains and plasmids. Strains and plasmids used in this study are specified in
Supplemental Table SII. Strains were derived from S288C strains BY4741 and
Y709242,43. All integrations and deletions were made using homologous
recombination. To express TbDot1A, TbDot1B or hDot1L from the endogenous
yeast DOT1 locus, first DOT1 was replaced by a URA3 selection cassette using the 5’
and 3’UTR flanking sides. Subsequently, the URA3 cassette was replaced by ORF
sequences amplified by PCR from pCJ49 (TbDot1A), pFF019 (TbDot1B) and
pFvl925 (hDot1L). To obtain strains expressing different concentrations of Dot1
enzyme, different promoters were integrated,100 base pairs upstream of the DOT1
gene (leaving part of the 5’UTR), or immediately upstream of the START codon.
Promoter sequences were amplified from pYM-N6 (NatMX-ADHpr), PYM-N14
(NatMX-GPDpr), pYM-N18 (NatMX-TEFpr). To generate NKI6123, the TbDot1A
gene was replaced by URA3 from pRS306 in NKI6099 (NKI6107). Subsequently,
URA3 was replaced by a NatMX-ADHpr-hDot1L1-430 PCR product (NKI6120) and
a 9xMyc-KanMX was added (NKI6126A) as described above. Finally, the TRP1-
GAL1pr-spacer-NLS-3xFLAG was PCR amplified from pIS013 and integrated in
frame with hDot1L in NKI6126A (NKI6123). The 9xMyc-tagging cassette from
pYM20 (9xMyc-HphNt1) was introduced distal of the N-terminal part of the gene,
thereby disrupting the STOP codon and allowing expression of a 9xMyc-tagged Dot1
protein. DOT1 was deleted using primers DOT1KO1 and DOT1KO2 together with
plasmid pRS306 (NKI6069) or pRS400 (NKI4506). pIS013was generated by cloning a
200 bp fragment consisting of NLS-3xFLAG from pUC57-NLSTAG3e into pTCG
using XhoI and BamHI. Subsequently, hDot1L was integrated using EcoRI and SalI
sites to allow expression of NLS-3xFLAG-hDot1L1-430 (pTW125).
H3K79 methylation pattern analysis. For analysis of H3K79 methylation and Dot1
protein expression cells were harvested in mid-log phase as described previously and
in the Supplemental Methods. Quantitative western blot analysis was performed
using the LI-COROdyssey IRDyeH IR imager (Biosciences) and the Odyssey LI-COR
software. For details about the normalization of the H3K79methylation signals based
on the linearity of the antibodies, see the Supplemental Methods. Histone H3
purification for mass spectrometry and determination of growth rates was performed
as described previously22. Data were obtained of at least two replicates.
Computational simulations of H3K79 methylation patterns. A previously
described model21 was used to simulate H3K79 methylation patterns and estimate in
vivoDot1 rate constants. To simulate time-dependent changes inH3K76methylation
during the course of the cell cycle in trypanosomes, the distributive model for Dot1
methylation was integrated with histone dynamics during the cell cycle (see
Supplemental Methods).
RITE assay. Recombination Induced Tag Exchange (RITE) strains in which yeast
DOT1 was deleted were transformed with pTW100 (TbDot1A) or pTW098
(TbDot1B), while a DOT1 wild-type RITE strain was transformed with pFvl261
(empty vector). To track how yDot1, TbDot1A and -B establish H3K79 methylation
patterns on newly synthesized histone H3, the RITE assay, which has been described
previously44,45, was slightly modified. Briefly, strains were grown during the full
experiment in YC media lacking tryptophan and containing 2% galactose as carbon
source. Cells were grown for three days into starvation, after which they were diluted
and grown to mid-log phase overnight. Cells were subsequently further diluted to
maintain cells in log-phase during the course of the experiment and ß-estradiol was
added to induce the recombinant-induced tag exchange from T7 to HAHIS on
histone H3. Samples for western blot were taken after each population doubling
(1 doubling per 3 hours in this media) and both old (H3-T7) as well as new
(H3-HAHIS) histones were detected using the anti-LoxP antibody44. H2A (39235,
Active Motif) or H2B (39237, Active Motif) detection was used as loading control,
while H3K79 methylation patterns were detected using the above described
antibodies. H3K79 methylation states on ‘‘new’’ H3-HAHis were quantified and
normalized to the average H3K79 methylation pattern (in %) of the 100% new
H3-HAHis strain (‘). The average H3K79 methylation pattern of the 100% new
H3-HAHis strain on western blot was compared to the steady state H3K79
methylation patterns presented in Figs. 1 and 2. The determined H3K79 methylation
levels by MS of the best matching strain was used as a reference for yeast cells
expressing yDot1 (yDOT1pr-yDot1), TbDot1A (TEFpr-TbDot1A) or TbDot1B
(GPDpr-TbDot1B) (Supplemental Table SIII).
Results
Here, we analyzed and compared the H3K79 methylation properties
of Dot1 enzymes from Saccharomyces cerevisiae (yDot1),
Trypanosoma brucei (TbDot1A and TbDot1B) and human
(hDot1L; Fig. 1A). We aimed to express the Dot1 enzymes from
the endogenous yDot1 locus in S. cerevisiae at different expression
levels to determine from the H3K79 methylation patterns whether
they act by a processive or distributive mechanism and to determine
their catalytic properties. To validate this approach, first yDot1 was
expressed from a series of four promoters, some of which were com-
bined with the 5’UTR region of yDot1, which is known to reduce
expression from ectopic promoters46. This resulted in a series of
promoter alleles that showed a wide range of expression levels
(Fig. 1B). As expected for yDot1, the H3K79me3 state increased
while the H3K79me1 and -me2 states decreased upon a gradual
increase of yDot1 protein expression (Fig. 1B), which is a con-
sequence of the distributivemechanism of yDot1. To generate quant-
itative data for mathematical modeling we analyzed H3K79
methylation patterns relative to wild-type methylation by quantitat-
ive immunoblot analysis and analyzed absolute H3K79 methylation
patterns by mass spectrometry (MS). The linearity of the antibodies
was determined usingMS data of a panel of selected yeast strains with
distinct H3K79 methylation states (see also below). The H3K79
methylation patterns determined by immunoblots (Fig. 1C and
Supplemental Fig. S1) correlated very well with the absolute
H3K79 methylation states determined by mass spectrometry
(Supplemental Table SI) confirming the linearity of the antibodies
(Fig. 1D).
Dot1 enzymes share a distributive kinetic mechanism but have
different apparent rate constants. Next, we used the same
promoter series to express TbDot1A and TbDot1B from the
yDOT1 locus. This resulted in yeast strains expressing a range of
Trypanosoma Dot1 protein levels which showed very divergent
global H3K79 methylation patterns (Fig. 2A–B). TbDot1A
generated a strong prominent H3K79me2 signal at intermediate
expression levels. However, at low expression levels H3K79me1
was more abundant, while H3K79me3 was found upon increasing
TbDot1A expression (Fig. 2A). TbDot1B almost exclusively
generated H3K79me3, also at low expression levels that are
www.nature.com/scientificreports
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Figure 1 | Quantitative H3K79 methylation analysis on a series of Dot1 alleles. A) Schematic overview of yeast Dot1, trypanosome Dot1A and Dot1B, and
humanDot1L. The enzymes share a conserved catalytic domain (grey box, CD). In addition, yDot1 contains anN-terminal domain with a lysine-rich domain
(light grey and white shaded box, respectively). Human Dot1L was expressed with part of its C-terminal domain that has weak similarity with the yDot1
N-terminal domain. B) Western-blot analysis of H3K79 methylation and yDot1 expression using specific antibodies. H3 and Pgk1 were used as loading
controls. A wild-type yeast strain (NKI6061;WT) was used as a reference throughout themanuscript; its H3K79methylation levels were determined by mass
spectrometry. A dot1D (–) was included to determine antibody specificity. Dot1 enzymes were expressed from the following promoters at the endogenous
yeast DOT1 locus: DOT1pr (D), TEFpr1 yDOT1 5’UTR (T*), GPDpr1 yDOT1 5’UTR (G*), ADHpr (A), TEFpr (T) or GPDpr (G). H3K79 methylation
patterns confirmed bymass spectrometry (MS) are indicated with¤. C)Western-blot analysis of a series of reference yeast strains (Y1-Y7) containing a range
of known H3K79 methylation levels (see below) to determine the linearity of the H3K79me1, -me2 and -me3 home-made (hm) antibodies22 and the
H3K79me2 antibody from Millipore (mp). Y1-Y7 refers to strains: NKI6081, NKI6077, NKI6084, NKI6099, NKI6100, NKI6085 and NKI6083. D) Samples
described in (C) were quantified using anOdyssey scanner and byMS. To determine the linearity of the H3K79methylation antibodies, MS data were plotted
against the quantified western-blot data and a non-linear regression fit was performed (see Supplemental Methods). The linear function resulting from the fit
was used to correct the quantified western-blot data described in thismanuscript and to subsequently estimate the unmethylatedH3 fraction.No linear fit was
obtained for theH3K79me2 home-made antibody; the low correlation betweenMS andwestern-blot data of theH3K79me2 homemade antibodywas caused
by cross-reactivity of this antiserum with H3K79me322. Unless stated otherwise, H3K79me2 was quantified using the Millipore antibody, since this showed
very little cross-reactivity to H3K79me3.
www.nature.com/scientificreports
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comparable to TbDot1A expression (Fig. 2B). H3K79me1 and -me2
were detected only at very low TbDot1B expression levels (see also
Supplemental Table SIIIA and additional data in Supplemental Fig.
S2). For both TbDot1 enzymes the relative abundance of the three
methylation states was variable upon changes in expression level,
which is in agreement with the distributive mechanism of action
that was recently demonstrated by in vitro methyltransferase
assays23.
We next analyzed hDot1L. Expression of hDot1L1-430 from the
promoters described above resulted in very low protein expression
for reasons that we do not understand. As an alternative approach,
we expressed hDot1L1-430 with a nuclear localization signal (NLS)
from a galactose-inducible promoter at the endogenous yDOT1
locus. Despite being expressed at levels higher than endogenous
yDot1 (Supplemental Fig. S4) the hDot1L protein showed a very
low catalytic activity when compared to the other Dot1 enzymes
studied here, resulting in mainly a small amount of H3K79me1. As
an additional approach, a galactose-inducible hDot1L allele on a
multi-copy plasmid was used to generate higher hDot1L expression
levels. Under that condition, H3K79me1 as well as H3K79me2 was
generated (Fig. 2D). The change in relative abundance of the H3K79
methylation states – increase in H3K79me2 without increased
H3K79me1 (Fig. 2D and Supplemental Fig. S3) – indicates that
hDot1L is a distributive enzyme. Taken together, our data suggest
that the distributive mechanism is conserved among Dot1 enzymes.
To perform a quantitative and unbiased assessment of catalytic
activities of the four histone methyltransferases, mathematical mod-
els for processive and distributive enzymes were used. These models
simulate histone H3K79 methylation dynamics in the cell to reveal
the kinetic mechanism and obtain estimates of the rate constants of
the respective methylation steps. Yeast is especially well suited for
computational modeling because of the ease of ectopic expression
and the availability of a unique data set of endogenous protein copy
numbers. Besides experimental H3K79 methylation patterns (deter-
mined by western blotting and MS), other data used were Dot1
concentration (determined by western blots with tagged yDot1 as a
reference with a known copy number) (Figs. 1B and 2, Supplemental
Table SIII), growth rates (Supplemental Table SIII), and the H3
concentration in the cell (http://yeastgenome.org/). Rate constants
for the respective methylation steps in this model represent the best
estimations of the kcat/Km ratio for each methylation action in vivo.
More complicated enzyme kinetic equations typically have toomany
parameters to allow a unique fit to the available experimental data.
Moreover, the Dot1 substrate S-adenosyl-methionine (AdoMet) was
assumed to be constant. The kinetic constants in this study therefore
represent apparent rate constants.
Figure 2 | Quantitative assessment of H3K79/K76methylation by TbDot1A, TbDot1B and hDot1L.Western-blot analysis of H3K79methylation states
generated by TbDot1A (A), TbDot1B (B) and hDot1L (C) upon expression from the yDOT1 locus in yeast. H3K79 methylation states were determined
using specific H3K79 methylation antibodies and the Dot1 enzymes were detected using their Myc and/or Flag tags. H3 and Pgk1 were used as loading
controls. H3K79 methylation patterns that were confirmed by mass spectrometry are indicated with¤. A-B) TbDot1A (A) and TbDot1B (B) enzymes
were expressed from the same promoter series as described in Fig. 1B. C) hDot1L was expressed in yeast from the GAL1 promoter at the endogenous
yDOT1 locus (Flag-hDot1L-9xMyc) upon induction by 2% galactose as the sole carbon source in rich medium. D) hDot1L was expressed in yeast from
the GAL1 promoter at the endogenous yDOT1 locus (Flag-hDot1L-9xMyc) or at a multi-copy plasmid (2m-hDot1L-Flag) upon induction by 2%
galactose as the sole carbon source in the minimal medium. Human Dot1L protein expression levels are shown in Supplemental Fig. S4.
www.nature.com/scientificreports
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This approach previously revealed that yDot1 is a distributive
enzyme and that different rate constants are required for the estab-
lishment of H3K79me1 (k0), -me2 (k1) and -me3 (k2)21. Before apply-
ing this approach to H3K79 methylation patterns of the TbDot1
enzymes and hDot1L, the procedure was applied to the extended
yDot1 dataset (Supplemental Table SIIIA, Fig. 3 and Supplemental
Fig. S3). The analysis confirmed the distributivemechanism of yDot1
and validated the robustness of our experimental system.
Furthermore, the model generated similar in vivo rate constants as
described byDeVos et al21 (Table I). Subsequently, we evaluated how
well the H3K79 methylation patterns of TbDot1A and -B could be
predicted by elementary processive and distributivemodels. For both
enzymes, simulations with the distributive model resulted in a good
fit of the experimental data, whereas modeling with the processive
model did not fit the experimental data as well (Fig. 3). This con-
firmed that both TbDot1A and -B are distributive enzymes (Fig. 3).
As expected from the observed different steady-state H3K79
methylation patterns, TbDot1A and -B had different estimated rate
constants compared to each other and to yDot1. In trypanosomes,
TbDot1A expression has been linked to high H3K76me2.
Interestingly, the estimated rate constants suggest that the predom-
inant accumulation of H3K79me2 by TbDot1A in yeast is not the
result of high dimethylation efficiency (k1) but of a,30 fold reduced
trimethylation efficiency (k2) compared to yDot1, preventing rapid
Figure 3 | Dot1 enzymes share a distributive mode of action. Experimental data of H3K79 methylation patterns generated by yDot1, TbDot1A, and
TbDot1B in yeast and simulations using the models for distributive and processive enzymes as described in De Vos et al (2011)21. For each enzyme, the
experimental H3K79 methylation pattern data that passed the quality test (presented in Fig. S3 and Supplemental Table SIII) were used to model the
kineticmechanismof theDot1 enzymes. For yDot1, data fromFrederiks et al22 were included. A subset of this dataset was confirmed bymass spectrometry
analysis (see Supplemental Table SIII for numeric data). Simulations for hDot1L are shown in Supplemental Fig. S4. Each graph represents the H3K79
methylation patterns of yeast strains expressing a Dot1 enzyme at different concentrations. Each tick on the x-axis represents a single yeast strain.
Simulations with the distributive model generated a better fit with the experimental data than the simulations with the processive model, as shown by the
lower sum of squares values (SS).
Table I | Predicted rate constants (mM–1min–1) for Dot1 enzymes
H3K79me kx yDot1* TbDot1A TbDot1B
H3K79me0
# k0 0.050 (0.055) 0.045 0.018
H3K79me1
# k1 0.021 (0.019) 0.022 0.32
H3K79me2
# k2 0.010 (0.0087) 0.00037 0.078
H3K79me3
*values indicated between brackets were reported in De Vos et al, 2011.
www.nature.com/scientificreports
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conversion of H3K79me2 into H3K79me3 (Table I and
Supplemental Table SIV). TbDot1B expression in trypanosomes is
associated with high H3K76me3 levels. Indeed, TbDot1B has a high
k2 when compared to yDot1 or TbDot1A; it is able to establish
H3K79me3 ,8 times faster than yDot1. Surprisingly however, the
k1 value revealed that TbDot1B is also a very efficient dimethylase
since it generates H3K79me2,15 times more efficiently than yDot1
and TbDot1A (Table I and Supplemental Table SIV). In contrast,
even though TbDot1B can mono-, di-, and trimethylate histone H3
without the help of TbDot1A, it is,2.5 fold slower in the establish-
ment of H3K79me1 (k0) than yDot1 and TbDot1A. This is not unex-
pected because in trypanosomes, TbDot1B predominantly acts on
H3K76 that was previously di- (or mono-) methylated by
TbDot1A12. This and possible roles for the strong dimethylase activ-
ity of TbDot1B will be discussed below.
Finally, we attempted to model the experimental data of hDot1L.
However, a relatively low quality fit was obtained as a result of the
extremely high copy number estimation for hDot1L when expressed
from the multi-copy plasmid (Supplemental Fig. S4 and
Supplemental Table SIII). Likely, the estimated copy number is not
representative for the active hDot1L fraction in the cell since the
estimated enzyme concentration is,5 fold higher than the substrate
(H3) concentration. Therefore, we could not further model the
experimental data of hDot1L to obtain reliable estimates of the rate
constants. However, our results do suggest that the hDot1L protein
shows a very low catalytic activity compared to yeast or
Trypanosoma Dot1 proteins. Together, our findings show that the
conserved Dot1 enzymes share a distributive catalytic mechanism
with some rate constants remarkably similar, while other constants
seem to have diverged resulting in unique H3K79 methylation
properties.
Dot1 rate constants determine the kinetics of H3K79methylation
in the cell. To examine how the apparent rate constants impact on the
kinetics of H3K79methylation in the cell, the accumulation of H3K79
methylation states was studied on newly synthesized unmodified
histone H3 using a variant of the Recombination-Induced-Tag-
Exchange (RITE) system44. Briefly, in log-phase cells, induction of
Cre-recombinase activity resulted in a genetic switch from an old
epitope-tag on histone H3 to a new tag (Fig. 4A). Using this tag-
switch system, newly synthesized histone H3 molecules have a
different tag than the old H3 molecules already present in the cell.
The two H3 species differ in size and were simultaneously detected by
an antibody against the common spacer peptide (LoxP). In the
experimental set-up used here, the percentage of cells
in the population that performed Cre-mediated recombination and
produces ‘new’ H3-HAHis increases during the course of the
experiment. As a consequence, H3 with a new tag represents a mix
of histones of different ages. However, the average age of the ‘new’H3-
HAHis histones increases over time. The establishment of H3K79
methylation on new histones (upper band) was followed using
H3K79 methylation antibodies (Figs. 4B-D and Supplemental Fig.
S5). In the strain constitutively expressing yDot1, new histone H3
proteins initially contained H3K79me1 and -me2 but low
H3K79me3 levels (e.g. see the 2-doubling time-point where old and
new histone H3 are present at similar levels). The H3K79me3 levels
Figure 4 | Kinetics ofH3K79methylation of new histones.Dot1methylation activity on newly synthesized histones was tracked using amodified version
of the Recombination-Induced Tag Exchange (RITE) assay in yeast44. A) The only gene present encoding for histone H3 (HHT2) was tagged with a RITE
cassette (LoxP-T7-Hyg-LoxP-HAHis), which resulted in expression of H3 tagged with T7, also referred to as the ‘‘old’’ histone. Addition of b-estradiol in
log phase induced recombination between the LoxP sites (and deletion of the T7-hygromycin (HYG) cassette), resulting in the production of ‘‘new’’ H3
tagged with HAHis. Since recombination occurs asynchronously and takes a few hours before it is completed in a population of cells, the percentage of
cells in the population that underwent RITE and producedH3-HAHis increased during the course of the experiment. As a consequence, H3with a new tag
represented a mix of histones of different ages; this age distribution changed over time. B-D) Western-blot analysis of H3K79 methylation levels on new
(upper band) and old (lower band) histone H3 in the presence of yDot1 (B), TbDot1A-HA-TAP (C) and TbDot1B-HA-TAP (D). Samples were taken
upon one, two or three population doublings (Doubling5 1, 2, or 3). As controls, samples were taken immediately after the addition of b-estradiol (100%
‘‘old’’, Doubling5 0), and from strains that expressed only theH3-HAHis (100% ‘‘new’’,‘). Antibodies against H2A (yDot1) orH2B (TbDot1A and -B)
were used as loading controls. The percentage of recombination was determined for each sample at the different time points. The graphs represent the
average H3K79 methylation levels on newly synthesized histone H3 of which at least two replicates were available. H3K79 methylation states (relative to
H2A/H2B and normalized to the new H3 signal of the LoxP blot) were converted into estimated absolute methylation levels by using as a reference the
100% new strain (‘; see Supplemental Fig. S5).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 9824 | DOI: 10.1038/srep09824 6
increased at later time points (Fig. 4B). This is in agreement with the
expectation for a distributive enzyme that new histone H3 initially
acquires H3K79me1, which is then converted into H3K79me2 and
H3K79me3 (given that for yDot1 k0. k1. k2).
The TbDot1A and -B enzymes were constitutively expressed from
a plasmid in a dot1D RITE strain. Expression of TbDot1A or –B did
not affect the kinetics of Cre recombination mediated genetic tag
switch (Fig. 4B–D). In the presence of TbDot1A, H3K79me2 signals
were rapidly detected on new histone H3, while H3K79me3 only
accumulated later in time (Fig. 4C). These observations are in agree-
ment with the low k2 of TbDot1A. Furthermore, the changing ratios
between the individual H3K79 methylation states confirm the dis-
tributive nature of the enzyme. In the presence of TbDot1B, almost
exclusively H3K79me3 was detected on newH3 (the H3K79me1 and
H3K79me2 blots are essentially empty). Some H3K79me2 was
detected early on (after one population doubling), while no
H3K79me1 could be identified on old or new histone H3
(Fig. 4D). This is in agreement with the very high estimated values
for k1 and k2 relative to that of k0. One consequence of the low k0, high
k2, and very high k1 of TbDot1B is that supply of H3K79me1 is slow
while its conversion into H3K79me2 and further to H3K79me3 is
rapid, leading to a seemingly binary switch from H3K79me0 to
H3K79me3. As hDot1L had very low activity and methylated only
a small percentage of histone H3 under steady-state conditions, we
did not perform this assay for hDot1L. However, we conclude that
the distributive mechanism and highly different catalytic activities
predicted for yDot1, TbDot1A and TbDot1B based on steady state
measurements are consistent with the kinetics of H3K79methylation
on newly synthesized histones.
Simulations of H3K76 methylation in trypanosomes. In
trypanosomes, TbDot1-mediated H3K76 methylation is tightly
linked to cell cycle progression12,38. To gain more insight into how
the cell-cycle regulated pattern is generated and how sensitive it is to
perturbation, the estimated rate constants were used to parameterize
a model that represents H3K76 methylation in trypanosomes. The
model accounts for one 13-hour cell cycle of procyclic (insect stage)
trypanosomes12 in which the G2/M, S and G1 phases take up
respectively 40%, 20% and 40% of the time47. Since no data were
available for TbDot1 enzyme regulation or expression, TbDot1 cell
cycle regulation and expression levels were adjusted in the model
(Supplemental Fig. S6) until the simulations represented the H3K76
methylation states based on cell staining12,38 in trypanosomes
(Fig. 5A and Supplemental Fig. S6; and see Supplemental
Methods). For example, no H3K76me1 or -me2 has been observed
in S phase, but H3K76me1 and -me2 accumulate during G2 followed
Figure 5 | Simulation of H3K76 methylation throughout the trypanosome cell cycle. Simulation of H3K76 methylation in a 13-hour procyclic
trypanosome cell cycle divided in an S-phase (20%), G2/M-phase (40%) and G1-phase (40%). TbDot1A and -B expression was manually set to
approximately fit the reported experimental data12,38 (see main text). Furthermore, adjustments were made in the model to simulate H3K76methylation
patterns in TbDot1A or -B depleted or overexpressing trypanosomes. A) Expression of TbDot1A in G2/M and G1 with 1500 copies and expression of
TbDot1B only during G1 with 3000 copies resulted in a model that simulated the experimental data best. B) TbDot1B was excluded from the model to
simulate a TbDot1B knockout. C) To simulate TbDot1A overexpression studies, TbDot1A expression was increased to 3000 copies per cell and
continuously expressed (c) during the cell cycle. D) To simulate TbDot1A knockdown studies, TbDot1A expression was lowered to 600 copies per cell. E)
TbDot1A was excluded from the model to simulate a TbDot1A knockout. F) To simulate TbDot1B misregulation studies, TbDot1B was continuously
expressed (c) during the cell cycle.
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by anH3K76me2 peak inmitosis38. To recapitulate this pattern in the
model, TbDot1A becomes active after S-phase at the start of G2/M to
generate H3K76me1 and H3K76me2 (Fig. 5A). Subsequently,
H3K76me1 and -me2 signals rapidly decrease in G1. Therefore, in
the model, TbDot1B becomes active at the start of G1 to mediate the
rapid transition from H3K76me1 and -me2 to exclusively
H3K76me3 during G112 (Fig. 5A). The levels of TbDot1A and
TbDot1B expression used in the model were validated by
determining the consequences of moderate changes in the
parameters. Changes in TbDot1A expression resulted in altered
H3K76 methylation patterns that are in disagreement with
experimental data (Fig. 5, Supplemental Fig. S6 and Supplemental
Methods). The TbDot1B copy number in the model was less critical
than that of TbDot1A because a small increase or decrease in
TbDot1B levels did not affect the efficient transition to
H3K76me3. Also, alternative timing of TbDot1A and -B during
the cell cycle resulted in models that did not recapitulate the
observed H3K76 methylation pattern in wild-type trypanosomes
(Supplemental Fig. S6). Although attempts to detect endogenous
TbDot1A/B expression as a function of the cell cycle in
trypanosomes have failed12, it will be interesting to obtain more
information on the regulation of the enzymes during the cell cycle
in future studies.
Next, we examined whether parameter variations that mimic
changes in TbDot1A or -B expression in trypanosomes recapitulate
the altered H3K76 methylation signals observed in trypanosomes.
First, deletion of TbDot1B from trypanosomes results in loss of
H3K76me3 and enhanced H3K76me2 signals12. This is adequately
recapitulated by our model in which H3K76me2 accumulates during
G1 in the absence of H3K76me3 (Fig. 5B). Second, trypanosome cells
constitutively overexpressing TbDot1A have enhanced H3K76me2
signals in S- and G2-phases38. Similarly, our model predicts
enhanced H3K76me2 (and -me1) during S-phase and G2/M upon
TbDot1A overexpression (Fig. 5C). We conclude that our model
predicts H3K76 methylation states in trypanosomes accurately.
Furthermore, the model indicates that TbDot1A functions as a timer
in G2/M through the consecutive establishment of an H3K76me1
peak during G2 and an H3K76me2 peak during mitosis (Fig. 5A).
Finally, we used the model to gain insight into several experi-
mental TbDot1A/B perturbations that cause trypanosome lethality
or sickness. First, depletion of TbDot1A causes replication pro-
blems38. Our model for procyclic cells predicts a reduction in
H3K76me2 levels upon a 2.5-fold reduction of TbDot1A (Fig. 5D).
In addition to this expected abundance change12,38, our model also
shows altered timing of the H3K76me1 and –me2 signals. Second,
ectopic expression of TbDot1A causes constitutive replication38. In
Figure 6 | Expression of TbDot1A or TbDot1B in yeast affects silencing but not replication. A) Cell cycle progression of yeast strains overexpressing
yDot1, TbDot1A or TbDot1B was determined by flow cytometry (FACS) analysis of DNA content and compared to the wild-type strain NKI6061 (WT).
X-axis depicts DNA signal, Y-axis depicts cell count. The promoter from which the Dot1 enzymes were expressed is indicated behind the dash:
A5ADHpr, G5GPDpr, D5DOT1pr. Strain Y7092 was used as the WT control for yDot1-G. B) To test whether the altered H3K79 methylation profiles
affected silencing of the silent HMLa mating locus yeast strains expressing yDot1, TbDot1A or TbDot1B in aMATa ADE2 1 leu2D background were
mated with a WT strain with aMATa ade2D LEU21 background (BY4726). Loss ofHMLa silencing inMATa cells leads to loss of mating type identity
and loss ofmating ability. Cells were plated in 10-fold serial dilutions on selective syntheticmedia. Diploids that result from effectivemating wereADE21
LEU2 1 and able to grow on –ADE –LEU media. C) Telomeric silencing was examined in a strain (UCC7164) containing a telomeric URA3
reporter (TEL-VII-L) and telomeric ADE2 reporter (ADE2-TEL-VR). Plasmid-based Dot1 expression was induced with 3% galactose53. Cells were plated
in 10-fold serial dilutions on selective synthetic media with or without 5-FOA. Cells that silence URA3 can grow on 5-FOA media whereas cells that
expressURA3 cannot. Cells that silence ADE2 accumulate a red pigmentwhereas cells that expressADE2 arewhite. TbDot1AG138A andTbDot1BG121A
show H3K79 methylation activity, while TbDot1A 138R and TbDot1B G121R have lost their ability to methylate H3K7953. D) Yeast strains
expressing yDot1, no Dot1, partially active yDot1 (DN and G401A)21, TbDot1A or TbDot1B were plated in 10-fold dilution series on rich media
with or without 100 mM hydroxyurea (HU). Loss of mating type identity by TbDot1A or –B expression (see panel B) was eliminated by deletion of
the HMLa1/2 genes.
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addition to the expected increase in overall levels of H3K76me2 (area
under the red curve in Fig. 5C) there is a predicted premature appear-
ance of H3K76me2 in S-phase. Interestingly, the computational
model also suggests that one of the predominant changes under those
conditions is the premature appearance of H3K76me1 in S-phase
(Fig. 5C). Since a premature predicted appearance of H3K76me2 in
S-phase in TbDot1B knock-out cells is not associated with replica-
tion problems (Fig. 5B), this suggests that H3K76me1 and not
H3K76me2 might be the signal causing replication defects in cells
with ectopic TbDot1A expression. Third, knock-out of TbDot1A or
constitutive overexpression of Dot1B is lethal12,38. According to the
model, deletion of TbDot1A leads to loss of H3K76me2, whereas
constitutive TbDot1B expression leads to increased H3K76me3.
However, the model suggests that also the H3K76me1 levels during
the cell cycle are severely affected (Fig. 5E-F) under both conditions.
In summary, TbDot1A/B perturbations that according to the model
change H3K79me1 timing in S-phase or G2/M are lethal (TbDot1A
knock out, ectopically expressed TbDot1A, or ectopically expressed
TbDot1B) (Fig. 5). The presence of H3K76me1 in
S-phase upon constitutive TbDot1A expression might cause con-
tinuous replication and thereby lethality12,38. Similarly, the delay in
the H3K76me1 signal in a TbDot1A-depleted cell might be respons-
ible for the abolished replication12,38.
Effect of excess H3K79me2 and H3K79me3 on yeast growth and
silencing. Having created yeast strains with unusually high H3K79
methylation levels, and given the proposed role of yDot1 in yeast cell
cycle progression and gene silencing2,25,48–52, we examined whether
conditions of excess H3K79me2 and H3K79me3 affected growth or
gene silencing. In yeast cells expressing TbDot1A, the H3K79me2
levels are,80%, which is,4 fold higher than wild type. In yeast cells
expressing TbDot1B, virtually all H3 is trimethylated, which is ,2
fold higher than wild-type cells (e.g. see Supplemental Table S1).
Remarkably, in these cells no cell-cycle changes were observed by
FACS analysis of DNA content (Fig. 6A). Also in limiting dilution
spot tests no growth defects were found in the absence or presence of
DNA replication inhibitor hydroxyurea. (Fig. 6B–D). These results
suggest that in budding yeast hyper H3K79 methylation is not
detrimental for cell-cycle progression. However, silencing of
telomeric reporter genes and the native mating type locus HMLa
was severely compromised by TbDot1A or –B expression (Fig. 6B–
C). These results suggest that H3K79me3 as well as H3K79me2 can
act as disruptors of silencing. The strong desilencing effects also
suggest that TbDot1A and TbDot1B are efficient competitors of
the SIR complex, which binds to and silences telomeric regions
and mating type loci. Yeast Dot1 overexpression affected silencing
much less, even though this also led to a global increase in
H3K79me3. In contrast to yDot1, the trypanosome Dot1 proteins
do not require the N-terminal tail of histone H453, a part of the
nucleosome important for recruitment of the SIR complex.
Therefore, it is possible that TbDot1A and TbDot1B, in contrast to
yDot1, are able to methylate regions occupied by the SIR complex
and thereby weaken the silencing activity of the SIR complex.
Discussion
The mechanism of action of histone methyltransferases has been
subject of intensive research3,20–32. Here, we report that Dot1
enzymes from yeast, trypanosomes and humans share a distributive
mechanism. However, the four Dot1 enzymes with a conserved
catalytic domain generate highly divergent H3K79 methylation
patterns upon expression in yeast, which is a consequence of the
specific activities of each enzyme.
Our findings that TbDot1 enzymes function in a distributive
manner in living cells are in agreement with very recent studies
showing that both TbDot1 enzymes methylate recombinant tryp-
anosome nucleosomes in vitro in a distributive manner23. In our in
vivo experiments we obtained data that enabled the determination
of estimated rate constants for TbDot1A and TbDot1B. This
yielded several new important insights. First, TbDot1A was less
efficient than TbDot1B and yDot1 in generating H3K79me3.
However, it generated substantial amounts of H3K79me3 upon
increasing concentrations. In contrast, in the same cellular envir-
onment, hDot1L was unable to generate H3K79me3. This was
unexpected because hDot1L, like TbDot1B, contains a conserved
tyrosine in the D-loop of its methyltransferase domain that was
recently suggested to be important for trimethylase activity23
whereas TbDot1A lacks this residue. Second, TbDot1B is less effi-
cient in generating H3K79me1 but rapidly generates H3K79me3.
The structural basis for the different substrate specificities of
TbDot1A and TbDot1B was recently demonstrated by elegant
homology-based modeling experiments and in vitro assays23.
Interestingly, our experiments show that TbDot1B also generates
H3K79me2 extremely efficiently (Table I). In accordance with our
predictions, converting TbDot1A into a better trimethylase by
domain swaps with TbDot1B also transformed TbDot1A into an
enzyme with higher dimethylation rates in vitro23. A high dimethy-
lase activity of TbDot1B may be unexpected since TbDot1A was
shown to be the main generator of H3K76me2 in trypanosomes12.
In view of the distributive mechanism of TbDot1A and TbDot1B, it
is logical, however, that TbDot1B requires efficient H3K76me2
formation. TbDot1B needs to remove any remaining H3K76me1
that was not yet converted to H3K76me2 by TbDot1A to obtain an
H3K79me2 substrate for further conversion to the final trimethyla-
tion state (see Fig. 5).
The insights into the catalytic activity of the TbDot1 enzymes in
combinationwith the simulations ofH3K76methylation throughout
the trypanosome cell cycle has revealed several interesting features
about the dynamics and regulation of H3K76 methylation. First,
TbDot1A seems to function as a molecular timer like yDot121 and
efficiently generates two distinct methylation states during G2/M
(first H3K76me1, then H3K76me2) without the need for additional
factors that regulate H3K76me levels, such as putative demethylases.
The predicted temporal control of H3K76me1 during the T. brucei
cell cycle and the association with replication errors and viability (see
Results section above) suggests that it may serve as a specific critical
signal. In this view, the high rate constant of TbDot1B for the syn-
thesis of H3K79me2 (k1) might be required to rapidly remove any
remaining H3K76me1 at the onset of G1.
A second interesting feature is that co-operation of two distribu-
tive Dot1 enzymes is needed to generate a cell cycle dependent
H3K76 methylation pattern. This implies that the system is flexible
but also sensitive to perturbations and might require additional sta-
bilizing mechanisms. For example, a prolonged cell cycle affects the
H3K79 methylation pattern in yeast21 and could possibly affect
H3K76me1 and -me2 in trypanosomes during G2/M as well. In
contrast, the global H3K76me3 signal during the cell cycle seems less
sensitive to perturbations as moderate changes in expression of
TbDot1A or TbDot1B, or the loss of TbDot1A, have minor effects
on the rapid global trimethylation of H3K76 (Fig. 5 and
Supplemental Fig. S6). Thus, the model suggests that the timing of
both TbDot1A and -B and the expression level of TbDot1A is tightly
regulated during the cell cycle (Supplemental Fig. S6).
Finally, lowering the average expression but not changing the
timing of TbDot1A and -B activity in the model progressively dis-
turbs the cell cycle regulated H3K76 methylation states but not the
global methylation levels (Supplemental Fig. S7). This indicates that
global H3K76 methylation levels may be a sub-optimal reporter of
Dot1 inhibition in Trypanosomes. The data we presented here start
to unravel the importance of H3K76 methylation and TbDot1A and
-B regulation in trypanosomes. Further in vivo experiments will be
important for validation of our predictions.
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Our findings suggest that hDot1L also acts by a distributive
mechanism. This is in agreement with recent biochemical and
structural studies showing that hDot1L has an occluded active site.
Most likely, hDot1L requires conformational rearrangements to
allow for binding of the substrate lysine and release of the reaction
by-product S-adenosyl-homocysteine (SAH) and reloading of the
methyl donor S-adenosyl-methionine (SAM)18,24. The catalytic
domain of hDot1L expressed in yeast has relatively low activity
when compared to the other Dot1 enzymes investigated here.
However, the observed abundance of lower H3K79 methylation
states is generally in line with the steady-state H3K79 methylation
patterns observed in human cells37. For example, HeLa cells have a
H3K79 methylation pattern that consists of 77% unmethylated H3,
20% H3K79me1, and 2.5% H3K79me2, whereas H3K79me3 was
not detected by mass spectrometry37. In its native environment in
the cell, hDot1L activity may be influenced by its assembly into one
of the complexes in which it has been found7,54–56. hDot1L has been
shown to be assembled into the Dot1.Com complex and interact with
RNA polymerase II, AF9, AF10, and Bat38,57–59. Such interactions
might facilitate the conformational changes in the hDot1L structure
needed to allow for binding and releasing SAM and SAH, respect-
ively18,24. Protein-protein interactions also target hDot1L to specific
sites in the genome8,57–59, thereby locally increasing H3K79 methyla-
tion. It remains to be investigated if hDot1L in such a complex is still
distributive or constitutes a pseudo-processive mechanism. Indeed,
hDot1L and RNA polymerase II colocalize at transcription start sites,
where H3K79me2 is enriched6,8,58,60 and recruitment of hDot1L to
H3K9-acetylated chromatin throughAF9 correlateswith the presence
of H3K79me359. Therefore, it is possible that within the cell a certain
fraction of the hDot1L enzyme pool acts in a pseudo-processive man-
ner and that similar rules apply to Dot1 proteins in other species.
Our analysis of Dot1 proteins with highly distinct catalytic prop-
erties from evolutionary distinct organisms shows that Dot1
enzymes across species share a distributive mode of action. As has
been the case for yeast Dot1, the insights in the catalytic mechanism
of Dot1 enzymes in humans and trypanosomes will help to further
unravel and understand the mechanisms that regulate the activity of
H3K79/76 methylation in health and disease.
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